Status
Ongoing
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with Sildenafil an ingredient found in an FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Status
Ongoing
Classification
Class I
Report Date
December 27, 2023
Termination Date
—